Managing risky meds
July 15, 2014
‘HIGH-RISK medicines: how to
avoid errors’, published in Health
News and Evidence, focuses on
‘Practice Points’ around managing
medicines most associated with the
most severe adverse events.
In the latest systematic review,
the medicines digoxin, warfarin,
aspirin and the drug classes beta
blockers, NSAIDs and opioids were
among those accounting for the
largest percentage of fatal and nonfatal
events.
Non-fatal outcomes included
disability, life-threatening
conditions, hospitalisations and
extended hospitalisations.
CLICK HERE to view the paper on
NPS MedicineWise’s site.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jul 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jul 14